Blincyto (blinatumomab) - Astellas, Amgen
Kimmtrak (tebentafusp-tebn) - Immunocore
edratide (hCDR1) - XTL Biopharma
Talvey (talquetamab-tgvs) - J&J
Tecvayli (teclistamab-cqyv) - Genmab, J&J
Columvi (glofitamab-gxbm) - Roche
Imdelltra (tarlatamab-dlle) - Amgen
Lunsumio (mosunetuzumab-axgb) - Roche
http://www.ncbi.nlm.nih.gov/pubmed/40987715
 
Hyeonmin Lee; Junho Chung; Yonghee Lee
 
Sep 24, 2025
 
Next